In acute pancreatitis, ICAM-1 is upregulated in various organs and contributes to the development of organ injury. To investigate the effects of pancreatic proteases on ICAM-1 expression and their role in the early process of leukocyte migration, human umbilical vein endothelial cells (HUVECs) were incubated with serum subjected to limited trypsin digestion and Wistar rats were injected with trypsin. Significant upregulation of membrane-bound ICAM-1 was seen on HUVECs incubated with trypsinated serum. Likewise, soluble ICAM-1 increased in the supernatant of HUVECs. Changes of membrane-bound ICAM-1 and soluble ICAM-1 were maximal with high concentrations of trypsin. HUVECs incubated with TNF-alpha (positive control) showed similar changes. In the pancreas and lungs of animals infused with trypsin, ICAM-1 and leukocyte sequestration were increased compared with controls. Reflecting the relevance of protease-induced ICAM-1 expression in leukocyte migration, leukocyte-endothelium interaction, as assessed by intravital microscopy, was markedly increased by trypsin. Inhibition of ICAM-1 ameliorated these changes significantly. In conclusion, trypsinated serum induces the upregulation of both membrane-bound ICAM-1 on endothelial cells and soluble ICAM-1. These changes contribute to the early steps of leukocyte migration in acute pancreatitis. The role of soluble ICAM-1 remains to be investigated.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajpgi.00221.2004DOI Listing

Publication Analysis

Top Keywords

membrane-bound icam-1
16
leukocyte migration
16
soluble icam-1
16
acute pancreatitis
12
icam-1
12
huvecs incubated
12
icam-1 upregulated
8
migration acute
8
icam-1 expression
8
endothelial cells
8

Similar Publications

The family of heterodimeric CD11/CD18 integrins facilitate leukocyte adhesion and migration in a wide range of normal physiologic responses, as well as in the pathology of inflammatory diseases. Soluble CD18 (sCD18) is found mainly in complexes with hydrodynamic radii of 5 and 7.2 nm, suggesting a compositional difference.

View Article and Find Full Text PDF

Intercellular adhesion molecule 1 (ICAM-1) is a central cell adhesion molecule for retinal transendothelial migration of the leukocytes in non-infectious posterior uveitis. Inhibiting gene transcription reduces induction of ICAM-1 in inflamed retinal endothelium. Based on published literature implicating transcription factor ETS-1 as an activator of gene transcription, we investigated the effect of ETS-1 blockade on ICAM-1 levels in cytokine-stimulated human retinal endothelial cells.

View Article and Find Full Text PDF

Intercellular adhesion molecule-1 (ICAM-1) is a transmembrane glycoprotein expressed on immune, endothelial, and epithelial cells. Its ectodomain can be proteolytically cleaved to release a circulating soluble form called sICAM-1. Clinical studies demonstrate sICAM-1 is upregulated in various diseases and associated with disease severity.

View Article and Find Full Text PDF

Extracellular vesicles as biomarkers for AIDS-associated non-Hodgkin lymphoma risk.

Front Immunol

November 2023

UCLA AIDS Institute and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States.

Article Synopsis
  • Extracellular vesicles (EVs) are membrane-bound particles released by cells that carry bioactive molecules and may play a role in diagnosing and treating certain cancers, including AIDS-related non-Hodgkin lymphoma (AIDS-NHL).
  • The study analyzed serum samples from 51 AIDS-NHL cases and 52 HIV+ controls, measuring levels of specific EV markers (like PD-L1 and others) before diagnosis using advanced assays.
  • Results showed that higher levels of EVs containing PD-L1, CD40, TNF-RII, and IL-6Rα were significantly linked to an increased risk of developing AIDS-NHL, suggesting these EVs may serve as potential early biomarkers for this condition.
View Article and Find Full Text PDF

Cytotoxic CD8 +T lymphocytes (CTLs) are key players of adaptive anti-tumor immunity based on their ability to specifically recognize and destroy tumor cells. Many cancer immunotherapies rely on unleashing CTL function. However, tumors can evade killing through strategies which are not yet fully elucidated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!